Fianlimab (Anti-LAG3 / CD223)
Fianlimab (Anti-LAG3 / CD223) is a human monoclonal antibody that targets the immune checkpoint receptor LAG-3 on T cells. It has anti-tumour activity and can be used in treatment of advanced melanoma. MW :145.72 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2995 |
| Sku # | A2995-1mg*25 |
| Pricing | 1mg*25, $5070.00 |